TCL Archive CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans. November 5, 2004
TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive Magnson Makes It Clear Senate Will Add Substantial Sums To Budget, Objects To Training Grant Phaseout May 17, 1974
TCL Archive DCT Board Approves Recommendations For Clinical Trials; Some Controversial November 9, 1979
